Aimil Pharmaceuticals: Taking Ahead The Legacy Of Ayurveda To Transform Healthcare

Dr Ikshit Sharma, Director

Dr Ikshit Sharma

Director

There has been a remarkable surge in research and development in the Indian pharmaceutical sector over the past five years that has solidified its po­sition as a leader in delivering affordable generic drugs, herbal medicine, medical equipment, and vaccines. This phenomenon is attributed to its ability to manufacture high-quality, cost-effective medicines, leveraging inno­vative manufacturing methods. The digitalization of bio­technology, among other techs like big data analytics and AI, has changed the scene of R&D. India's pharmaceutical industry has registered great strides despite having made meager investments in R&D compared to those of devel­oped countries. The progressive governmental policies, coupled with increased domestic and foreign investments in R&D, will facilitate continuous growth of this sector, as well as ensure its global recognition. In many cases, how­ever, the pharmaceutical companies face obstacles, includ­ing resource allocation for R&D, regulatory barriers, com­petitive pressures, and the need for clinical evidence.

Aimil Pharmaceuticals harnesses Ayurveda's ancient wisdom, delivering natural products through robust R&D for predictable therapeutic benefits worldwide. Prioritizing regulatory compliance, safety, and quality assurance, the firm ensures that products meet global standards. By conducting thorough clinical studies, the company accurately assesses efficacy, identifies modifications, and tailor’s treatments to individual needs.

Transforming Health with Ayurvedic Innovations

Since its establishment, Aimil Pharmaceuticals has had its fair share of the pie in India's pharmaceutical sector, primarily known for being a pioneer in natural herbal Ayurvedic solutions. This firm uses a strategy that combines ancient healing traditions with modern scientific progress that has curated an extensive array of products serving various medical conditions. From its inception, Aimil has continuously raised its standard in the pharmaceutical industry and is being ranked within the top 100 pharmaceutical companies, according to IMS figures. This success is backed by an extensive marketing network, which reaches over 350,000 doctors through more than 2000 marketing personnel, and expansion globally in more than 30 countries. Aimil Pharmaceuticals remains committed under the visionary leadership of its managing director, K K Sharma, who has been globally promoting phyto-healing for four decades. The international market base cements it as a frontline player, particularly within Ayush Pharmaceuticals, where it holds the number two position. The company combines traditional medicinal knowledge with state-of-the-art scientific research methodologies. This approach allows the company to develop innovative products that meet consumers' changing needs and preferences. Strategic partnerships with prestigious institutions such as DRDO, CSIR, IVRI, and TATA ACTREC further bolster the company's capabilities and reinforce its position as an industry leader.

Aimil Pharmaceuticals specializes in Ayurvedic medicines, Animal health care & personal care products, promoting health & wellness globally

Dr Ikshit Sharma, Director

Empowering Health through Ayurvedic Wisdom

Aimil Pharmaceuticals offers a wide array of products and services, specializing in authentic Ayurvedic medicines, Animal health care and personal care products. The firm's portfolio includes diverse segments. It provides solutions for tough to treat disease conditions and offers a range of natural personal care products. It contributes to the ONE HEALTH MISSION with Ayurvedic animal healthcare products and aims for HEALTH FOR ALL in over 30 countries. “Committed to quality, safety, and efficacy, Aimil Pharmaceuticals ensures that all products meet rigorous standards, serve a global clientele, and earn trust through reliable healthcare solutions”, says Dr Ikshit Sharma, Director.

Aimil Pharmaceuticals is distinctive in the pharmaceutical market due to an assemblage of unique factors that make it successful. The company's commitment to scientific innovation and research excellence enables the development of new products for the management of critical health conditions that provide holistic solutions for diseases such as leucoderma, recurrent kidney stones, UTI, and liver health issues, among others. Additionally, this emphasis on innovation is supplemented by a wide-ranging product portfolio within different therapeutic segments, allowing healthcare professionals and patients to choose from various treatment options. Aimil Pharmaceuticals stands firm in terms of quality and regulatory compliance; hence, this guarantees products' consistency with the stringent industrial standards. This unwavering dedication establishes confidence among stakeholders, both healthcare providers and patients themselves. Diversity, accompanied by a full grasp of the entire pharmaceutical value chain, from product development to regulatory affairs along with marketing, fuels the company's growth and success. With a staff capacity of over 3,000, the company boasts about its strong team, which has expansive knowledge bases and is responsible for introducing innovative new medications and therapies. This expertise spans from conceptualization to clinical trials and regulatory approval, ensuring efficient progress through each stage of development. In marketing and sales, the team builds strategies that target the audience and increase product adoption by applying knowledge about market trends, customer preferences, and competitors' landscapes to make products more influential and gain a significant market share. The R&D team's dedication to continuous learning and skill enhancement is supported by investments in training programs, workshops, and seminars, ensuring that researchers are equipped with the latest tools and knowledge.

Aimil Pharmaceuticals envisions a future of innovation across its product range, focusing on emerging trends and changing patient needs. The organization also plans to provide personalized medicine and digital health solutions while adding organic, vegan and cruelty-free products rooted in Ayurvedic principles. By 2030, the organization aspires to be globally recognized as providers of modern, globalized Ayurvedic healthcare solutions addressing diverse health issues. It tirelessly aims to deliver quality, innovative healthcare solutions that successfully take advantage of Ayurveda's scientific heritage in a progressive manner.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.